Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 5Head and Neck Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Carcinoma 2Adenocarcinoma 2Sexual Dysfunction, Physiological 1Pyridoxine-dependent epilepsy 1Peripheral Nervous System Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neurotoxicity Syndromes 1Neoplasm Metastasis 1Mouth Neoplasms 1Glioblastoma 1Esophageal Neoplasms 1Erectile Dysfunction 1Astrocytoma 1Abdominal Cancer 1

Interventions

Psychiatric Rehabilitation 4Surveys and Questionnaires 3Radiotherapy 3Counseling 3Sildenafil Citrate 2methyl N-acetylsibirosaminide 1methyl 3-mercaptopropionimidate 1bicalutamide 1Vitamin D 1Therapeutics 1Testosterone Propionate 1Testosterone 1Tadalafil 1Surgical Procedures, Operative 1Restraint, Physical 1Radiosurgery 1Prostatectomy 1Pilocarpine 1Phenylephrine 1Phentolamine 1Papaverine 1Nutrition Assessment 1Mindfulness-Based Stress Reduction 1Menogaril 1Magnetic Resonance Spectroscopy 1Low Density Lipoprotein Receptor-Related Protein-1 1Leuprolide 1Interviews as Topic 1Hormonal Contraception 1High-Intensity Focused Ultrasound Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Sexual Dysfunction, Physiological × Tadalafil × Clear all
NCT00931528 2018-02-14

Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy

Radiation Therapy Oncology Group

Phase 3 Completed
242 enrolled 13 charts
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡